Tuesday, September 22, 2026

$FOUR: Shift4 at 6.5x EBITDA. Is the organic growth real? | Emeth Value Capital

Shift4 trades at 6.5x EBITDA despite 11% reported organic growth, with Shift4 Dine equipment leases cited as evidence of net-new merchant additions.

FOUR $2.9B

Yet Another Value Podcast Sep 22 21 clicks

Sep 22 VSH $5.8B

Analog Semiconductor Smorgasbord, Feat. TXN, ON, VSH

Cestrian Capital Research 6 clicks

Sep 22 FLY $3.9B

Monte Investments Market Brief Vol. CXXVIII

Monte Independent Investment Research 9 clicks

From X

@stockgutter Sep 16

SG on X

@schubertperson no idea re 2023 but Dream Finders just announced a transformative acquisition of $BZH, so it seems it will be a very different co in a year

@DOMOCAPITAL Sep 16

DOMO Capital Management, LLC on X

Farm Bill with year-round #E15 advances out of Senate Ag Committee $ALTO $GPRE

@DeepSailCapital Sep 16

Deep Sail Capital on X

Can Hertz $HTZ Squeeze Again? https://t.co/JGSpzf0sYQ

@pennycheck Sep 16

⚽️📡 on X

Interesting to note $DKNG largest volume gain in prediction mkt volume over last seven days https://t.co/34Zg2HaCoT

@TheBenSchmark Sep 16

JabroniCoin.USD on X

Publicly traded Lifetime Fitness $LTH actually did engineering and product innovation in pickleball. Built a more durable and consistent ball that eventually became PPA tournament-official. https://t.co/w8N1bsRIpW

@ACapitalLP Sep 16

A Capital on X

Someone risked $37.5k of premium selling itm December $PRKS put spread to bet on a Hill Path take private and the thin float exacerbated the move?

@ACapitalLP Sep 16

A Capital on X

$FUN vs. $PRKS 👀

@BlueDuckCap Sep 16

BDC on X

$AIRS needs to refi their debt. Its a mega catalyst which we have no reason to believe won't happen. "term sheets on our desk". Been a frustrating stock and mgmt still has a lot to prove. Think they are the right team, but again, show me. GLP1 creating all sorts of new aesthetic demand. ASPS flagged lift/contour as the defining category. Facial fat grafting +39%, brow lift +29%, upper body lift +22%, arm lift +21%, neck lift +21%, thigh lift +20%, facelift +13%, breast lift +8% — broadest gains in the report, tied to post-GLP-1 skin laxity. AIRS has direct shots on goal to address much of this (not all). They also have partnered on AlloClae which looks timely. Checks here are encouraging. Minimally invasive still dominant by volume. Neuromodulators (~50%) and HA fillers (~30%) account for most non-surgical treatment volume — the space AIRS's new AlloClae partnership targets. These new pockets of growth need to offset what was a -1% lipo print in 2025 per ASPS. Still #1 by volume, though. Time to make it happen, Yogi. The opportunity is too big and timely for it to not start showing up. Start by signing those term sheets.

Cellebrite (CLBT) Management Meeting: The Road Ahead

Cellebrite converts more than 110% of EBITDA into free cash flow and trades at 12.5 times free cash flow, with management targeting 15% or…

CLBT $2.8B

Aurelion Research Sep 22 9 clicks

Meta's Muse Could be Big Win for Innodata

Innodata's new Meta contract for long-horizon agent personalization ties the data company to Meta's Muse AI assistant, despite Meta's Scale…

INOD $2.4B

Hunterbrook Sep 22 12 clicks

Undercovered Dozen: Rithm Capital, Sterling Infrastructure, Corning And More

Undercovered Dozen spotlights 12 lesser-covered stocks, including Rithm Capital, Sterling Infrastructure and Corning.

RITM $5B

The Undercovered Dozen Sep 22

Emeth Value Capital’s Andrew Carreon on Shift4 ($FOUR)

Shift4 trades at 6.5 times EBITDA despite 11% organic growth, with Shift4 Dine equipment leases reaching a $400 million run rate as…

FOUR $2.9B

Yet Another Value Blog Sep 22 4 clicks

Copart's Return To Growth Starts Now: Adair's $1.9B Bet On ACV Auctions

Copart’s $1.9 billion ACV Auctions acquisition targets renewed growth, with EPS accretion expected by fiscal 2028 as insurance…

ACVA $1.8B

Robert J. Lake Sep 22 2 clicks

Quick Value #331 - Corteva / Vylor Spin-Off

Corteva will spin off its Pioneer seed business, Vylor, on October 1, leaving crop protection RemainCo that could trade at 6.5-8.5x 2026…

CTVA $8.4B

Value Don't Lie Sep 21 5 clicks

[CoStar] Homes are different

CoStar spent more than $1 billion building Homes.com to challenge Zillow, betting seller-agent leads, proprietary listing content and…

ZG $6.2B

scuttleblurb Sep 21 4 clicks

ARKO. 3x Owner’s Earnings multiple, 21% ROCE, Founders involved and large shareholders, Stake in a public company>market cap. Superb Capital Allocators

ARKO trades at 3 times estimated 2025 owner’s earnings, while its 73.6% APC stake exceeds its $473 million market cap.

ARKO $453M

Calvin Blissett Sep 21 4 clicks

Bioventus: Cash Flow Anchors The Bull Case Beyond A Potential Sale

Bioventus uses established-product cash flow to cut debt and fund launches, while its 2030 term loan extension and lower margin support its…

BVS $1.1B

Equity Eagle Sep 21

I Tested Three Cannibals Against Dillard’s. I Bought Two. (CROX, CNX, GPI)

Crocs, CNX and Group 1 are tested against Dillard’s buyback-driven share-count reduction, with Group 1 leading and CNX’s convertible notes…

CROX $5.7BCNX $4.7B

Cannibal Stocks Sep 20 2 clicks

TRIP · long

Tripadvisor INC

Tripadvisor (TRIP) is presented as a long idea.

TRIP $985M

Value Investors Club Jun 24 5 clicks

Aggressive Portfolio Trades: Buy Vail Resorts, Buy ORR, Short GEO

Vail Resorts, down 60% since 2022, is pitched for an El Niño-driven ski-season rebound; the portfolio also buys ORR and shorts GEO.

MTN $5.1BGEO $4B

Ian’s Insider Corner Sep 20 9 clicks

🍔New Chapter 11 Bankruptcy Filing - Meritage Hospitality Group Inc.🍔

Meritage Hospitality, a 320-unit Wendy’s franchisee, filed Chapter 11 amid $137 million of bank debt, $391 million of leases and a…

WEN $1.2B

PETITION Sep 20 3 clicks

Bumble, 2x Owner’s Earnings. Sentiment is abysmal, the founder is back. The stock could easily be a multibagger.

Bumble trades at roughly 2x owner’s earnings and 4.76x enterprise value, with Whitney Wolfe Herd’s return central to a rerating case.

BMBL $335M

Calvin Blissett Sep 20 4 clicks

Who Really Runs Crocs? The Autopsy.

Crocs CEO Andrew Rees turned around the core brand, then borrowed $2 billion for HEYDUDE, whose $737 million write-down followed wholesale…

CROX $5.7B

Cannibal Stocks Sep 19 5 clicks

Karman: Why I'm Upgrading To Buy After A 68% Drop

Karman Holdings (KRMN) is upgraded after a 68% drop, with 24% organic growth, a $1.3 billion backlog and higher 2026 guidance offset by…

KRMN $4.3B

Dhierin Bechai Sep 19 1 click

QNT: The 100× Question

Quantinuum's improving logical-qubit error correction, 1,504 successful-circuit benchmark score and paid deployments at RIKEN, BMW and…

QNT $1.9B

Mispriced Assets Sep 18 3 clicks

DeFi Development: The Clarity Act Failure Tests The Solana Treasury Thesis

DeFi Development’s Solana treasury strategy faces dilution, preferred dividends and tight liquidity after a 50% rally, with $4.3 million of…

DFDV $175M

Dorine Cherop Sep 18

Research & Analysis: Ultra Clean Holdings (NASDAQ: UCTT)

Ultra Clean Holdings targets a $4 billion annualized revenue run rate by H2 2027 through manufacturing expansion and a broader…

UCTT $3.5B

Monte Independent Investment Research Sep 18 2 clicks

Anterix: The Spectrum Case Is Real, But The Chart And The Insiders Say Wait

Anterix’s 900 MHz spectrum could be worth $2.5–$7 billion, versus a $1.41 billion enterprise value, but insider selling and lumpy…

ATEX $1.5B

The Market Auditor Sep 18 2 clicks

Tuesday, September 22, 2026

SG on X

DOMO Capital Management, LLC on X

Deep Sail Capital on X

⚽️📡 on X

JabroniCoin.USD on X

A Capital on X

A Capital on X

BDC on X

Investor Letters

Publications we follow

Newsletters 93

YouTube 4

Blogs 12

Seeking Alpha 42 of 199

X accounts we follow

Investor letters we follow

Sectors